By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endo Pharmaceuticals 

100 Endo Boulevard

Chadds Ford  Pennsylvania  19317  U.S.A.
Phone: 610-558-9800 Fax: 610-558-8979



Company News
Depomed (DEPO) Announces Two Favorable Decisions In Inter Partes Review Proceedings Versus Endo Pharmaceuticals (ENDP) 9/23/2015 11:36:51 AM
Endo Pharmaceuticals (ENDP) And BioDelivery Sciences International (BDSI) Present New Data On Investigational Product Buprenorphine Hcl Buccal Film For Chronic Pain Management 9/9/2015 6:40:27 AM
Endo Pharmaceuticals (ENDP) Announces XIAFLEX For Dupuytren's Contracture Formal Pricing In Japan; Commercial Launch Set For September 16, 2015 8/31/2015 6:58:14 AM
Endo Pharmaceuticals (ENDP) Completes Divestiture Of American Medical Systems, Inc. (AMMD)' Men's And Prostate Health Businesses To Boston Scientific (BSX) 8/4/2015 6:37:54 AM
Endo Pharmaceuticals (ENDP) Continues Expansion With $8.05 Billion Acquisition of Par Pharma 5/18/2015 6:05:19 AM
Endo Pharmaceuticals (ENDP) And BioDelivery Sciences International (BDSI) Present Pivotal Data From Two Phase 3 Trials Demonstrating Safety And Efficacy Of Buprenorphine Hcl Buccal Film For The Management Of Chronic Pain 5/15/2015 6:21:12 AM
Endo Pharmaceuticals (ENDP) Shells Out $130 Million for Nearly 70 Pipeline Programs From Aspen Pharmacare 5/11/2015 5:56:51 AM
Braeburn Pharmaceutical Expands Pipeline To Include Schizophrenia With Endo Pharmaceuticals (ENDP) Deal 5/1/2015 7:53:56 AM
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015 7:25:43 AM
BioDelivery Sciences International (BDSI) To Receive $10 Million Milestone Payment From Endo Pharmaceuticals (ENDP) In Conjunction With Acceptance Of NDA For BELBUCA (buprenorphine HCl) Buccal Film For Chronic Pain 2/23/2015 7:34:37 AM